AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Jul 19, 2021

6990_rns_2021-07-19_f252f61e-5089-47fb-9313-508a6c99c07f.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

�������� ��������� ���� 2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8544
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 19/07/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-118812 Time of broadcast: 13:51 13:51

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on_________

Board_nomination_July2021_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 15/06/2021
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2

Talk to a Data Expert

Have a question? We'll get back to you promptly.